CXCL8 was also found to be significantly upregulated in HCC, promoting tumor progression and metastasis through activation of the AKT/mammalian rapamycin target protein (mTOR)/STAT3 pathway [47]. This evidence concerns the gene CXCL8 and hepatocellular carcinoma.